BRUSSELS, Belgium - There is a slowdown in the volume of useful new drugs on the European market, and biotech is in part to blame, according to the leading European pharmaceutical industry association. (BioWorld International)

Max Planck Innovation GmbH, the technology transfer arm of Germany's Max Planck Society, has spun out a new subsidiary, the Lead Discovery Center GmbH (LDC), to take forward innovative, early stage projects that are as yet unready for commercial out-licensing deals. (BioWorld International)